Maravai LifeSciences Holdings Inc
Company Profile
Business description
Maravai LifeSciences Holdings Inc is a life sciences company that provides critical products that drive the development of groundbreaking vaccines, drug therapies, cell and gene therapies, and diagnostics. The group's solutions empower research into human diseases and support the entire biopharmaceutical development process from early discovery to commercialization. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.
Contact
10770 Wateridge Circle
Suite 200
San DiegoCA92121
USAT: +1 858 546-0004
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2025
Employees
580
Stocks News & Analysis
stocks
Going into earnings, is Alphabet stock a buy, a sell, or fairly valued?
stocks
Going into earnings, Is Meta stock a buy, a sell, or fairly valued?
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,941.50 | 15.30 | 0.17% |
| CAC 40 | 7,750.71 | 47.51 | -0.61% |
| DAX 40 | 24,050.32 | 257.48 | -1.06% |
| Dow JONES (US) | 44,454.27 | 131.20 | 0.30% |
| FTSE 100 | 9,019.99 | 7.00 | 0.08% |
| HKSE | 25,130.03 | 135.89 | 0.54% |
| NASDAQ | 20,883.13 | 91.04 | -0.43% |
| Nikkei 225 | 39,774.92 | 44.19 | -0.11% |
| NZX 50 Index | 12,833.74 | 127.77 | -0.99% |
| S&P 500 | 6,304.28 | 1.32 | -0.02% |
| S&P/ASX 200 | 8,677.20 | 9.00 | 0.10% |
| SSE Composite Index | 3,581.86 | 22.07 | 0.62% |